Allergan & Johnson & Johnson Boast Q2 Profits-Yet Cut Jobs: The Sociopathic Business Model™
July 21, 2104 Allergan Q2 profits rise (to an estimated $1.86 billion) yet they cut 1,500 jobs. Johnson & Johnson Q2 profits rise 14.9% in US Sales yet they cut 400 jobs from Johnson & Johnson's DePuy Synthes and ending the PurTox development program will result in the elimination...